Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease

    Biomarkers are becoming increasingly important for the differential diagnosis of neurodegenerative diseases. Previous observations indicated neurofilament light chain (NfL) as a potential blood-based biomarker...

    Matthias Schmitz, Sezgi Canaslan, Juan Carlos Espinosa in Molecular Neurobiology (2022)

  2. Article

    Open Access

    Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers

    Lipocalin-2 is a glycoprotein that is involved in various physiological and pathophysiological processes. In the brain, it is expressed in response to vascular and other brain injury, as well as in Alzheimer’s...

    Peter Hermann, Anna Villar-Piqué, Matthias Schmitz in Alzheimer's Research & Therapy (2022)

  3. Article

    Open Access

    TREM2 expression in the brain and biological fluids in prion diseases

    Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune cell surface receptor that regulates microglial function and is involved in the pathophysiology of several neurodegenerative disease...

    Daniela Diaz-Lucena, Niels Kruse, Katrin Thüne, Matthias Schmitz in Acta Neuropathologica (2021)

  4. Article

    Open Access

    Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease

    Blood neurofilament light (Nfl) and total-tau (t-tau) have been described to be increased in several neurological conditions, including prion diseases and other neurodegenerative dementias. Here, we aim to det...

    Inga Zerr, Anna Villar-Piqué, Peter Hermann in Alzheimer's Research & Therapy (2021)

  5. No Access

    Article

    Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice

    Progressive motor alterations and selective death of striatal medium spiny neurons (MSNs) are key pathological hallmarks of Huntington’s disease (HD), a neurodegenerative condition caused by a CAG trinucleotid...

    Jordi Creus-Muncunill, Anna Guisado-Corcoll, Veronica Venturi in Acta Neuropathologica (2021)

  6. Article

    Open Access

    Ecto-GPR37: a potential biomarker for Parkinson’s disease

    α-Synuclein has been studied as a potential biomarker for Parkinson’s disease (PD) with no concluding results. Accordingly, there is an urgent need to find out reliable specific biomarkers for PD. GPR37 is an ...

    Xavier Morató, Paula Garcia-Esparcia, Josep Argerich in Translational Neurodegeneration (2021)

  7. No Access

    Article

    A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia

    Differential diagnosis of neurodegenerative dementia is currently supported by biomarkers including cerebrospinal fluid (CSF) tests. Among them, CSF total-tau (t-tau), phosphorylated tau (p-tau) and β-amyloid4...

    Daniela Diaz-Lucena, Geòrgia Escaramis, Anna Villar-Piqué in Journal of Neurology (2020)

  8. No Access

    Article

    Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia

    Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) share a couple of clinical similarities that is often a source of diagnostic pitfalls. We evaluated the discriminatory potential of brain-...

    Karin Gmitterová, Joanna Gawinecka in European Archives of Psychiatry and Clinic… (2020)

  9. No Access

    Article

    Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency

    Prion diseases, such as the sporadic Creutzfeldt–Jakob disease (sCJD), are a class of fatal neurodegenerative disorders. Currently, there is no efficient treatment or therapy available. Hence, the search for m...

    Matthias Schmitz, Niccolo Candelise, Eirini Kanata, Franc Llorens in Molecular Neurobiology (2020)

  10. No Access

    Article

    Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3

    Cerebrospinal fluid (CSF) non-phosphorylated tau (non-p-tau) is increased in sporadic Creutzfeldt–Jakob disease (CJD), but its accuracy in the differential diagnosis has not been previously established. Here, ...

    Franc Llorens, Anna Villar-Piqué, Peter Hermann, Matthias Schmitz in Journal of Neurology (2020)

  11. Article

    Open Access

    Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

    The clinical diagnosis of vascular dementia (VaD) is based on imaging criteria, and specific biochemical markers are not available. Here, we investigated the potential of cerebrospinal fluid (CSF) lipocalin 2 ...

    Franc Llorens, Peter Hermann, Anna Villar-Piqué in Nature Communications (2020)

  12. Article

    Open Access

    Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

    α-Synuclein is a small soluble protein, whose physiological function in the healthy brain is poorly understood. Intracellular inclusions of α-synuclein, referred to as Lewy bodies (LBs), are pathological hallm...

    Niccolo Candelise, Matthias Schmitz, Katrin Thüne in Translational Neurodegeneration (2020)

  13. Article

    Open Access

    Plasma YKL-40 in the spectrum of neurodegenerative dementia

    Increased plasma YKL-40 has been reported in Alzheimer’s disease (AD), but its levels in other neurodegenerative diseases are unknown. Here, we aimed to investigate plasma YKL-40 in the spectrum of neurodegene...

    Anna Villar-Piqué, Matthias Schmitz, Peter Hermann in Journal of Neuroinflammation (2019)

  14. No Access

    Article

    Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy

    High levels of total α-synuclein (t-α-synuclein) in the cerebrospinal fluid (CSF) were reported in sporadic Creutzfeldt–Jakob disease (sCJD). The potential use of t-α-synuclein in the discrimination of Lewy bo...

    Matthias Schmitz, Anna Villar-Piqué, Franc Llorens in Molecular Neurobiology (2019)

  15. No Access

    Article

    Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases

    Cerebrospinal fluid (CSF) total prion protein (t-PrP) is decreased in sporadic Creutzfeldt-Jakob disease (sCJD). However, data on the comparative signatures of t-PrP across the spectrum of prion diseases, long...

    Anna Villar-Piqué, Matthias Schmitz, Ingolf Lachmann, André Karch in Molecular Neurobiology (2019)

  16. No Access

    Article

    Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

    The analysis of the cerebrospinal fluid (CSF) biomarkers in patients with suspected prion diseases became a useful tool in diagnostic routine. Prion diseases can only be identified at clinical stages when the ...

    Franc Llorens, Tomás Barrio, Ângela Correia, Anna Villar-Piqué in Molecular Neurobiology (2018)

  17. No Access

    Article

    Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases

    The presence of protein deposits is a common pathological hallmark in patients suffering from neurodegenerative conditions and other proteinopathies. Deciphering the molecular basis of protein misfolding and a...

    Anna Villar-Piqué, Matthias Schmitz, Niccolò Candelise in Molecular Neurobiology (2018)

  18. Article

    Open Access

    Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

    The analysis of cerebrospinal fluid (CSF) biomarkers gains importance in the differential diagnosis of prion diseases. However, no single diagnostic tool or combination of them can unequivocally confirm prion ...

    Franc Llorens, Niels Kruse, André Karch, Matthias Schmitz in Molecular Neurobiology (2018)

  19. No Access

    Protocol

    Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion

    A characteristic feature of transmissible spongiform encephalopathies (TSE) is the progressive accumulation of protein aggregates in the brain in a self-propagation manner. Based on this mechanism, in vitro pr...

    Matthias Schmitz, Niccolò Candelise, Franc Llorens, Inga Zerr in Amyloid Proteins (2018)

  20. No Access

    Article

    Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress

    Cerebellar damage and granular and Purkinje cell loss in sporadic Creutzfeldt–Jakob disease (sCJD) highlight a critical involvement of the cerebellum during symptomatic progression of the disease. In this proj...

    Waqas Tahir, Saima Zafar, Franc Llorens, Amandeep Singh Arora in Molecular Neurobiology (2018)

previous disabled Page of 2